Men with gynecomastia may notice a rounded or swollen appearance of the chest, along with tenderness around the nipple. It’s also important to seek emotional support, as candy96.fun chronic gynecomastia also can impact mental health. Dealing with gynecomastia starts with addressing the underlying cause. If you suspect you have gynecomastia, it’s important to consult a healthcare provider for a proper diagnosis. Cordova and Moschella proposed a morphological classification of gynecomastia based on the evaluation of the relationship between the nipple-areola complex and the inframammary fold, which makes it possible to establish an algorithm for the most suitable intervention. Medical treatment can therefore be beneficial if implemented during the early proliferative phase, before the glandular structure has been replaced by stromal hyalinization and fibrosis. In the later stages (after 12m), there is marked stromal fibrosis, a slight increase in the number of ducts, but little to no epithelial proliferation and no inflammatory response. On average, gynecomastia surgery costs can range from $3,000 to $8,000. The gynecomastia surgery cost varies depending on factors such as the surgeon's expertise, geographical location, facility fees, and the extent of the procedure. Depending on the individual's needs, a combination of liposuction and glandular tissue excision might be performed for optimal results. Surgical intervention is considered when gynecomastia persists, causes significant discomfort, or affects self-esteem. Gynecomastia (enlarged male breast tissue) most often happens due to an imbalance of testosterone and estrogen. Gynecomastia, a condition characterized by the enlargement of breast tissue in males, can be a source of physical and emotional discomfort. Hormones such as estrogen and testosterone play a significant role in maintaining the balance of breast tissue in both males and females. Gynecomastia, a condition characterized by the enlargement of breast tissue in males, is a topic that deserves understanding and attention. Such evaluation is unnecessary for boys at puberty, for typical asymptomatic senile changes, for enlargement consisting mostly of adipose tissue, for men taking drugs known to cause gynaecomastia, or for physical findings strongly suggesting breast cancer. Table 2 shows other genetic markers considered possible risk factors for male breast cancer. Although prolactin (PRL) receptors are present in male breast tissue, hyperprolactinemia may lead to gynecomastia through effects on the hypothalamus, causing central hypogonadism.2,10,11 Activation of PRL also leads to decreased androgen and increased estrogen and progesterone receptors in breast cancer cells. E2 levels rise more rapidly than T during early puberty, which leads to an elevated estrogen/androgen ratio.4,7 In most pre-adolescent males, breast enlargement regresses concomitant with pubertal progression and the rise in T levels and so only small numbers of patients have persistent gynecomastia, and the condition usually spontaneously regresses within two years of onset. However, both conditions involve changes in breast tissue, and having gynecomastia does not increase a man’s risk of developing breast cancer. It is the benign enlargement of male or female breast tissue together, which occurs due to hormonal imbalances or other medical conditions. This review covers the causes, evaluation, and treatment of gynaecomastia and the risk factors for and evaluation and treatment of breast cancer in males. Ashkenazi Jews have a higher prevalence of BRCA1 and BRCA2 and an increased risk of male breast cancer than the general population.13 Male carriers of BRCA2 have a cumulative risk for breast cancer of 7% by age 80. Withdrawing an offending drug or treating an underlying disorder may be sufficient, especially if gynaecomastia is relatively recent. Most primary breast carcinomas in men are ductal, either invasive or non-invasive (ductal carcinoma in situ).16 Papillary histology is more common and lobular histology is rare in men (fig 3). Mammography is about 90% sensitive and 90% specific for malignant compared with benign masses in men.15 Invasive cancers are solid on ultrasonography. Imaging is not necessary if cancer is not suspected. Other important physical findings include adiposity, signs of hyperthyroidism, liver disease, hypogonadism (gynoid body habitus, decreased body hair, small testes consistent with Klinefelter’s syndrome), excessive musculature indicating candy96.fun exogenous androgen administration, or a testicular mass. Gynaecomastia is characterised by proliferation of ductules and loose connective tissue. But gynecomastia can also be a symptom of certain medical conditions that require treatment. In other words, an increase in estrogen and a decrease in testosterone most often leads to gynecomastia. Male breast cancer is much rarer than gynecomastia. A family history of breast cancer increases the risk of breast cancer in males. Men with Klinefelter’s syndrome, who have testicular failure shortly after puberty, have a 58-fold higher risk than normal males for breast cancer, with an absolute risk that approaches 3%.11 Breast cancer has been reported in male to female transsexuals who were castrated and given high dose oestrogen. We searched Medline for English language papers with the key words "gynaecomastia", "gynecomastia", and "male breast cancer"; the Cochrane database for clinical trials; our personal archives of references; and websites with those terms. But if it’s caused by long-term hormonal imbalances or other medical conditions then treatment is needed to reduce or get rid of the breast tissue. It is important to note that results are cosmetically unsatisfactory in 50% of patients. The effective dose of raloxifen (Rlx, an alternative anti-estrogen) was found to be 60 mg/day. Studies revealed that the effective dose range of Tmx in gynecomastia is 10-20mg/day for 2-4m. Although both Tmx and danazole have been used to treat gynecomastia, the effect of 20-mg/day Tmx gave 78% resolution, which was better 400-mg/day danazol, which had only a 40% resolution rate. In a randomized, double blind study, danazole significantly reduced breast tenderness and size. The first reported controlled trial investigating the efficacy of danazole in adult idiopathic gynecomastia was published in 1979 and showed that 200mg/day danazole could effectively control the symptoms, although no effect was found in cases of pubertal gynecomastia.